August 2016
- Daily Swims for a 90-Year-Old (WSJ)
- Henry Schein Joins IMF and LUGPA to Raise Awareness of Prostate Cancer and the Importance of Early Detection (PR Newswire)
- National Football League Alumni Association and Cancer Treatment Centers of America® Team Up for “Prostate Pep Talk” (Charleston Chronicle)
- Active Surveillance? Watchful Waiting? What Every Man With Prostate Cancer Should Know (Cancer.net)
- Pfizer Buying Maker of Prostate Cancer Drug Xtandi for $14B (Philly.com)
- Researcher Explores Biologic Basis for Disparities in Prostate Cancer Outcomes (OncLive)
- Continuing Docetaxel Therapy May Improve Survival in Prostate Cancer (Cancer Therapy Advisor)
- GPS for the Prostate Can Detect Cancer Earlier (11 Alive)
- Role of Vitamin D Receptor Gene Cdx2 and Apa1 Polymorphisms in Prostate Cancer susceptibility: a Meta-Analysis (BioMed Central)
- Cardiff University Receive Grant for ‘Pioneering’ Prostate Cancer Research (ITV)
- Accurate Risk Status Assessment Critical to Prostate Cancer Care (OncLive)
- Psychological Effects From ADT a Growing Challenge in Prostate Cancer (OncLive)
- Baltimore Breweries Aim to Raise Prostate Cancer Awareness with New Caps (Baltimore Sun)
- John McLaughlin, Provocateur of Public Affairs TV, Dies at 89 (The Washington Post)
- Alabama Woman to Receive National Certification to Train Cancer-Sniffing Dogs (AL.com)
- Sociodemographic Factors Impact Prostate Cancer Treatment Initiation (Cancer Therapy Advisor)
- Early Prostate Cancer Diagnoses Continue to Fall in U.S.: Study (US News Health)
- Incidence of Early Stage Prostate Cancer Lower After USPSTF Recommendation Against PSA Testing (Oncology Nurse Advisor)
- Integrating Diet and Exercise into Care of Prostate Cancer Patients on Androgen Deprivation Therapy (DovePress)
- New Treatment Target Found for Prostate Cancer Tumors (Speciality Pharmacy Times)
- Radiotherapy, Prostatectomy Confer Similar Outcomes for Aggressive Prostate Cancer (Healio)
- Online Programs Help to Address Effects of Prostate Cancer Treatment (OncLive)
- Quality of Life Similar For Men on Active Surveillance For Prostate Cancer vs Negative Biopsy (Medical Research)
- Custirsen Fails to Extend OS in Metastatic Castrate-Resistant Prostate Cancer (Healio)
- Men with Very High-Risk Prostate Cancer Live Longer with Radical Treatment (Prostate Cancer News Today)
- High-Grade Prostate Cancer Linked to Diabetes Drugs (Renal & Urology News)
- Researchers Pinpoint Key Regulatory Role of Noncoding Genes in Prostate Cancer Development (Medical XPress)
- Selenium May Cut Aggressive Prostate Cancer Risk (Renal & Urology News)
- Does a Prostate Cancer Therapy Up Alzheimer’s Risk? (Medscape)
- Compound Shows Promise as Next-Generation Prostate Cancer Therapy (Science Daily)
- A Tool to Aid Treatment Decisions in Prostate Cancer (AJMC)
- Computational Analysis of Prostate Cancer Networks Points Way to Patient-Specific Therapies (Prostate Cancer News Today)
- Grant to Support Research of Deadliest Form of Prostate Cancer (UF Health)
- Reserve ADT for African-American Men With High-Risk Prostate Cancer? (Cancer Network)
- One Year On: Inside Bayer’s Effort to Get Prostate Cancer Victims to Speak Up (PR Week)
- Idaho Woman Paddles the Yukon For Her Dad (Jackson Hole News & Guide)
- Caring for US Veterans Helped Lead Iraqi Immigrant to Develop Prostate Cancer Advances (OncLive)
- Cycling joy for former head teacher Trevor (York Press)
- Hormone therapy for prostate cancer may pose a risk for black men (Washington Post)
- High-dose radiation therapy as effective as surgery for aggressive prostate cancer (UCLA Health)
- European prostate cancer treatment is changing – what are the opportunities for marketers? (PMLive)
- Erectile Dysfunction Drugs: No Effect on Prostate Cancer Risk (MedScape)
- CrossFit Carries Paramus Father Through Cancer Treatment (Paramus)
- Analysis of metastatic prostate cancers suggests treatment options (University of Santa Cruz)
- Radiation Equal to Surgery for Prostate Cancer (Newsmax)
July 2016
- Harnessing the Immune System to Fight Cancer (NY Times)
- Robotic, Open Prostate Cancer Surgery Offer Similar Early Results (Renal & Urology News)
- Scientists Find Cancer in Million-Year-Old Fossil (CNN)
- Controversy Over Marvel’s Prostate Cancer Variant Covers (Bleeding Cool)
- Prostate Cancer Breakthrough Could Lead to new Diagnostic Tests and Treatments (Science Daily)
- Robotic Surgery for Prostate Cancer May Offer No Benefits Over Regular Surgery (NY Times)
- Protein ZMYND8 Tied to Suppression of Prostate Cancer Tumor Metasis (Science Daily)
- Occupational Exposure to Solar Ultraviolet Radiation and the Risk of Prostate Cancer (Uro Today)
- Prostate Cancer Isn’t Colorblind (NY Times)
- Decision Support and Shared Decision Making Help Patients Choose Plan for Low-Risk Prostate Cancer (Oncology Nurse Advisor)
- Expert Details Progression of Immunotherapy Agents in Prostate Cancer (Targeted Oncology)
- Tokai Pharma Shutters Prostate Cancer Drug Trial Early, Shares Crumble (Xconomy)
- Exploring Apalutamide in Patients with High-Risk Prostate Cancer (Targed Oncology)
- Markers that Cause Toxic Radiotherapy Side-Effects in Prostate Cancer Identified (Targeted Oncology )
- Dreicer Addresses Key Questions With Radium-223 in mCRPC (Onc Live)
- Word salad: What’s for dessert? (Healio)
- Shocking rise in advanced prostate cancer cases indicates men not following recommended screening regimen (Northern California News)
- One of the Quiet Oncology Heroes (Cure Today)
- Erroneous Study Of Advanced Prostate Cancer Criticized By Experts (Science World Report)
- Advanced Prostate Cancer On The Rise, Screening At Age 50 Key To Early Detection (The Huffington Post)
- HIFU Prostate Cancer Treatment Continues to Revolutionize Standard of Care (Prostate Cancer News Today)
- New Study Finds Cases Of Advanced (Metastatic) Prostate Cancer Rise Significantly In Last Decade – Are Changes To PSA Screening Guidelines To Blame? (PR News Wire)
- New Tool Helps Patients With Prostate Cancer Decide if Watchful Waiting is Right (Cure Today)
- Expert Stresses Importance of PSA-Based Screening in Early-Stage Prostate Cancer (OncLive)
- Advanced Prostate Cancer Cases Soar (AARP)
- Era of Precision Oncology for Prostate Cancer ‘Is Upon Us’ (Cancer Therapy Advisor)
- ASCO issues new guideline on chronic pain management in adult cancer survivors (ECancer News)
- Patnaik Highlights Evolution Toward Immunotherapy in Prostate Cancer (OncLive)
- Sun Pharma first to provide oncology treatments in ready-to-administer bags (Prostate Cancer News Today)
- Breast Cancer and ovarian cancer genes can be passed on by men to their children (Mirror)
- ST AMPEDE Trial and Patients with non-Metastatic Prostate Cancer (The Lancet)
- MCRPC: No Survival Benefit With Cabozantinib (MedPage Today)
- 225 Women Paddle for Prostate Cancer (CI News Today)
- Robot-Assisted Prostate Surgery Safe, Effective Long Term (Renal & Urology News)
- High Prostate Cancer Risk Linked to Inherited Mutations in DNA-repair Genes (Prostate Cancer News Today)
- ‘Smart’ nanoparticle called PEARLs a promising gem to target, treat tumours (EurekAlert!)
- Technavio Announces Top Four Trends for the Global Penile Implants Market through 2020 (Business Wire)
- Study Finds evidence that PD-1 Antibody may Benefit Men with Metastatic Prostate Cancer (News Medical)
- Familial Risk of Aggressive Prostate Cancer Quantified. (Renal & Urology)
- Prostate Cancer Patients Taking Statins Lived Longer (Renal & Urology News)
- Novel Agent Being Explored in Two Trials of High-Risk Prostate Cancer (Cure Today)
- Yoga May Benefit Men Undergoing Radiation for Prostate Cancer (Cure Today)
- Presence of P. acnes In Prostate Tissue Associated With Prostate Cancer (Cancer Therapy Advisor)
- U.S. Hospital Adopts ‘Watchful Waiting’ as Standard for Low-Risk Prostate Cancers Due to MRI Advances (Prostate Cancer News Today)
- Cabozantinib Not Superior to Prednisone for Pretreated mCRPC (Cancer Therapy Advisor)
- Researchers Estimate Familial Prostate Cancer Risk (Oncology Nurse Advisor)
- Dr Loppenberg on Benefits of Local Treatment for Metastatic Prostate Cancer (Onc Live)
- Statins: Could They Decrease Death Risk in Four Major Cancers? (Medical News Today)
- Mutations Suggest New Prostate Cancer Options (Med Page Today)
- Precision Medicine Initiative Gearing Up (Med Page Today)
- Inherited Mutations Common Among Men With Metastatic Prostate Cancer (Renal & Urology News)
- Leading Researchers Recommend Major Change in Prostate Cancer Treatment (Washington Post)
- Regulatory Endpoints for Approval: ORR, OS, or PFS? (Medscape)
- Robotic Rectum to Further Prostate Cancer Research (Reuters)
- Lymphovascular Invasion Helps Predict Post-RP Biochemical Recurrence (Renal and Urology News)
- Salmonella ‘Game-Changer’ Could Shrink Cancer Cells (BBC)
- Consumption of Tree Nuts Associated With Reduced Mortality for Patients With Prostate Cancer (Oncology Nurse Advisor)
- VA Plans Massive Expansion of Cancer Treatment Options (Military Times)
- Prostate Cancer: New Directions With Active Surveillance (Med Page Today)
- Prostate Cancer: Driving the Personalized Medicine Highway (Med Page Today)
June 2016
- Prostate Cancer: A Patient’s Journey (Med Page Today)
- Prostate Cancer Diagnoses Decline from 2011 to 2013 (Cancer Therapy Advisor)
- Study: Racially Biased Oncologists Spend Less Time With Black Cancer Patients (Atlanta Black Star)
- Researchers Working on Non-Invasive Prostate Cancer Diagnosis Using Urine Sample (Prostate Cancer News Today)
- Liquid Biopsy Biomarkers Identify Prostate Cancer Before Surgery (Science Daily)
- Smokers Face Delayed Continence Recovery After Prostate Surgery (Renal and Urology News)
- Drug Candidate Fexapotide Reduces Rates of Prostate Cancer in Men With BPH, Study Shows (Prostate Cancer News Today)
- Visceral Fat Predicts Prostate Cancer Treatment Outcomes (Renal and Urology News)
- Testosterone Replacement Safe for Men with Prostate Cancer (Renal and Urology News)
- ADT Plus Radiotherapy Boosts Survival in Metastatic Prostate Cancer (Cancer Therapy Advisor)
- Screening Smarter With PSA Testing (Med Page Today)
- RT Improved Survival Over ADT Alone in Metastatic Prostate Cancer (Cancer Network)
- Hypofractionated RT Effective for Localized Prostate Cancer (Cancer Therapy Advisor)
- Safety, Survival Advantage of Radium-223 Continues to Offer Benefit in mCRPC (Onc Live)
- NIH Rejects Petition to Override Patent on Pricey Prostate Cancer Drug (STAT)
- Disclosure of Specialty Bias Affects Patient’s Tx Choices (Med Page Today)
- Which ADT is Smarter for the Heart? (Medscape)
- Single PSA Cut-Point May Signal Progression (Med Page Today)
- Prostate Cancer: Informed Decisions or Information Overload (Med Page Today)
- Midlife PSA Levels Predict Lethal Prostate Cancer (Renal and Urology News)
- Preventing Overtreatment of Prostate Cancer: New Model Identifies Ideal Patients for Active Surveillance (Cancer Therapy Advisor)
- Can Liquid Biopsies and Tumor Biomarkers Personalize Prostate Cancer Treatment? (Cancer Network)
- Screening PSA Levels in Younger Men Could Accurately Predict Future Risk of Prostate Cancer (News Medical)
- Alterations in Metabolic Pathways in Prostate Cancer Hint at Potential New Treatments (Oncology Nurse Advisor)
- Tasquinimod Improves rPFS for Patients with Metastatic Castration-Resistant Prostate Cancer (Cancer Therapy Advisor)
- SBRT, Proton Beam Therapy Use Increasing for Prostate CA (Medical Xpress)
- ASCO: Switch in Taxane Chemo Boosts PSA Response in mCRPC (Med Page Today)
- ASCO: No Boost in PSA Response With PARP1 Inhibitor in mCRPC (Med Page Today)
- Laser Ablation Becomes Increasingly Viable Treatment for Prostate Cancer (Science Daily)
- ASCO: Intermittent Docetaxel May be Option in mCRPC (Med Page Today)
- ASCO: Docetaxel Still King in Chemo-Naïve mCRPC Patients (Med Page Today
- Prostate Cancer Risk Strongly Influenced by Breast and Ovarian Cancer History in Family: Study (Bel Marra Health)
- Letting Go: No Reduction in Aggressive Care for Advanced Cancer (Medscape)
- ASCO: Early Markers for Survival Could Speed Up Prostate Ca Research (Med Page Today)
- Scientists Identify Biomarker for Advanced Prostate Cancer as Specific Androgen Receptor in Circulating Cancer Cells (Prostate Cancer News Today)
- In Prostate Cancer, Xtandi Sparks More Fatigue and Pain Than Zytiga (Cure Today)
- ASCO: Combo Tx Fails in Local High-Risk Prostate Ca (Med Page Today)
- ASCO: Docetaxel Falls Short in High-Risk Prostate Cancer (Med Page Today)
- ASCO: Shorter RT Course OK in Mid-Risk Prostate Cancer (Med Page Today)
- Scientists Identify Biomarker for Advanced Prostate Cancer as Specific Androgen Receptor in Circulating Cancer Cells (Prostate Cancer News Today)